Konrads A, Hofbauer K G, Werner U, Gross F
Pflugers Arch. 1978 Oct 18;377(1):81-5. doi: 10.1007/BF00584378.
The direct action of arginine-vasopressin (AVP) and its deamino-D-arginine analogue (DDAVP) on renin release (RR) has been studied in isolated rat kidneys perfused with an electrolyte solution at constant pressure in a single-pass system. AVP and DDAVP infused at various concentrations (80 to 2100 pg/ml and 80 to 8700 pg/ml, respectively) reduced volume and increased osmolality of urine in a dose-dependent way. High doses of AVP reduced renal perfusate flow and glomerular filtration rate while DDAVP had no effect on renal haemodynamics. When vasoconstrictor doses of AVP or high concentrations of DDAVP were infused, "basal" RR remained unchanged. However, when RR had been stimulated by infusion of isoproterenol, vasoconstrictor doses of AVP as well as high doses of DDAVP which did not increase renal vascular resistance diminished RR by about 30% (P less than 0.01, and P less than 0.05, respectively). These results suggest that the inhibition of RR by vasopressin is not related to its vasoconstrictor action.
在单通道系统中,以恒压灌注电解质溶液的离体大鼠肾脏中,研究了精氨酸加压素(AVP)及其脱氨基-D-精氨酸类似物(DDAVP)对肾素释放(RR)的直接作用。分别以不同浓度(分别为80至2100 pg/ml和80至8700 pg/ml)输注AVP和DDAVP,以剂量依赖的方式减少尿量并增加尿渗透压。高剂量的AVP降低肾灌注液流量和肾小球滤过率,而DDAVP对肾脏血流动力学无影响。当输注血管收缩剂量的AVP或高浓度的DDAVP时,“基础”RR保持不变。然而,当通过输注异丙肾上腺素刺激RR时,血管收缩剂量的AVP以及未增加肾血管阻力的高剂量DDAVP使RR降低约30%(分别为P<0.01和P<0.05)。这些结果表明,加压素对RR的抑制作用与其血管收缩作用无关。